Quick Answer
Universe Pharmaceuticals INC reported Operating Income Loss of -$2.92 billion for the year ending 2025.
- Universe Pharmaceuticals INC showed an increase of +63.6% in Operating Income Loss from 2024 to 2025.
- This data is from Universe Pharmaceuticals INC's annual report (Form 10-K), filed with the SEC on January 29, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), Universe Pharmaceuticals INC's Operating Income Loss has declined by 29,998.2%.
- Historical annual values: Fiscal year 2025: -$2.92 billion | Fiscal year 2024: -$8.02 billion | Fiscal year 2023: -$3.97 billion | Fiscal year 2022: -$7.02 million | Fiscal year 2021: $13.59 million | Fiscal year 2020: $10.25 million | Fiscal year 2019: $9.75 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: